<?xml version="1.0" encoding="UTF-8"?>
<ref id="bjo16270-bib-0013">
 <label>13</label>
 <mixed-citation publication-type="journal" id="bjo16270-cit-0013">
  <string-name>
   <surname>Yao</surname>
   <given-names>X</given-names>
  </string-name>, 
  <string-name>
   <surname>Ye</surname>
   <given-names>F</given-names>
  </string-name>, 
  <string-name>
   <surname>Zhang</surname>
   <given-names>M</given-names>
  </string-name>, 
  <string-name>
   <surname>Cui</surname>
   <given-names>C</given-names>
  </string-name>, 
  <string-name>
   <surname>Huang</surname>
   <given-names>B</given-names>
  </string-name>, 
  <string-name>
   <surname>Niu</surname>
   <given-names>P</given-names>
  </string-name>, et al. 
  <article-title>In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)</article-title>. 
  <source xml:lang="en">Clin Infect Dis</source>
  <year>2020</year>
  <pub-id pub-id-type="doi">10.1093/cid/ciaa237</pub-id>
 </mixed-citation>
</ref>
